FDA To Study Television Drug Ads

Law360, New York (August 27, 2007, 12:00 AM EDT) -- A new government study will examine whether positive visuals in television drug advertisements interfere with the way viewers process potential side effects.

Under current regulations, pharmaceutical companies must include a “fair balance” of information in their direct-to-consumer advertising. However, many health care providers and consumers have expressed concern about the “compelling visuals” contained in the ads, according to the U.S. Food and Drug Administration.

“Ads can present information in ways that can optimize or skew the relative balance of risks and benefits,” the FDA said Wednesday...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.